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Paramyxoviral infection in childhood has been linked to a significant increased rate of
asthma development. In mice, paramyxoviral infection with the mouse parainfluenza virus
type I, Sendai virus (Sev), causes a limited bronchiolitis followed by persistent asthma
traits. We have previously shown that the absence of cysteine protease dipeptidyl peptidase I (DPPI) dampened the acute lung inflammatory response and the subsequent
asthma phenotype induced by Sev. Adoptive transfer of wild-type neutrophils into DPPIdeficient mice restored leukocyte influx, the acute cytokine response, and the subsequent
mucous cell metaplasia that accompanied Sev-induced asthma phenotype. However,
the exact mechanism by which DPPI-sufficient neutrophils promote asthma development
following Sev infection is still unknown. We hypothesize that neutrophils recruited to the
alveolar space following Sev infection elaborate neutrophil extracellular traps (NETs) that
propagate the inflammatory cascade, culminating in the eventual asthma phenotype.
Indeed, we found that Sev infection was associated with NET formation in the lung
and release of cell-free DNA complexed to myeloperoxidase in the alveolar space and
plasma that peaked on day 2 post infection. Absence of DPPI significantly attenuated
Sev-induced NET formation in vivo and in vitro. Furthermore, concomitant administration
of DNase 1, which dismantled NETs, or inhibition of peptidylarginine deiminase 4 (PAD4),
an essential mediator of NET formation, suppressed the early inflammatory responses to
Sev infection. Lastly, NETs primed bone marrow-derived cells to release cytokines that
can amplify the inflammatory cascade.
Keywords: neutrophils, NETs, cytokines, dipeptidyl peptidase I, Sendai virus-induced asthma

INTRODUCTION
Respiratory viral illnesses are common in early life. A majority of children with an initial episode
of viral-induced bronchiolitis will have recurrent wheezing, prompting the association between
viral infection, and subsequent development of asthma (1–3). In the mouse, infection with the
paramyxovirus Sendai virus (Sev) causes a limited bronchiolitis followed by chronic persistent
asthma traits characterized by mucous cell metaplasia and airway hyperreactivity (AHR) (4).
We have previously shown that the asthma phenotype was attenuated in the absence of dipeptidyl peptidase I (DPPI), a cysteine protease with many immunomodulatory activities (5). This
attenuation was accompanied by significant reduction in the number of alveolar neutrophils

Frontiers in Immunology | www.frontiersin.org

1

August 2016 | Volume 7 | Article 325

Akk et al.

NETs in Sev-Induced Inflammation

and local production of inflammatory cytokines in the acute
phase of infection. Adoptive transfer of WT neutrophils into
DPPI-deficient mice led to enhanced accumulation of DPPIdeficient neutrophils and inflammatory cytokine production in
the alveolar space on day 4 post-infection (PI) and subsequent
asthma phenotype development. The fact that DPPI-deficient
neutrophils exhibited normal chemotaxis in response to various
stimuli (5) but failed to accumulate at the site of inflammation (alveolar space) suggests a yet-to-be defined mechanism
by which DPPI and DPPI-sufficient neutrophils modulate the
early inflammatory responses to Sev.
Neutrophil extracellular traps (NETs) were initially described
as a neutrophil defense mechanism to trap and kill bacteria
(6). NETs have since been implicated in the pathogenesis of
several inflammatory diseases, including bronchial asthma (7).
Herein, we showed that Sev infection led to NET formation in
the lung of WT mice. We also established that DPPI-deficient
neutrophils exhibited a defect in NET formation in vitro in
response to multiple stimuli. We hypothesized that the absence
of DPPI attenuated NET formation in response to Sev infection,
thus interrupting the inflammatory cascade and suppressing the
ongoing leukocyte influx. Indeed, administration of DNase 1,
which dismantled NETs, reduced free DNA–myeloperoxidase
(MPO) complexes in the alveolar space and plasma, as well as
attenuating the early inflammatory responses to Sev infection.
Inhibition of peptidylarginine deiminase 4 (PAD4), an essential
mediator of NET formation also suppressed alveolar leukocyte
accumulation and cytokine production in the acute phase of
infection, confirming the contribution of NETs to Sev-induced
phenotype. Moreover, NETs from Sev-infected bronchoalveolar
lavage fluid (BALF) stimulated bone marrow-derived cells
(BMDCs) [dendritic cells (DCs) and macrophages] to release
inflammatory cytokines.

day on days 0–2 PI. Controls received the same volume of DMSO/
PBS (5% v/v). At different time points, mice were sacrificed and
their blood, BALF, and lung harvested for cell count, cytokine,
MPO–DNA, and histologic analysis.

Lung and BALF Analysis

After sacrifice, BALF was obtained as previously described (5). The
cells were pelleted and analyzed by flow cytometry using: FITC
anti-CD69 (cat# 561929; BD Pharmingen), PerCP anti-CD8a
(cat# 45-0081-82; eBioscience), APC anti-CD4 (cat# 100516;
BioLegend), PE anti-CD11c (cat#553802, BD Pharmingen), antiSiglec-H (cat# MCA4647GA, AbD Serotec, Raleigh, NC, USA),
APC anti-CD317 (cat# 127015, BioLegend), PerCP anti-CD11b
(cat# 101229, BioLegend), FITC anti-rat IgG (cat# 712-095-150,
Jackson ImmunoResearch Laboratories). In general, 106 cells were
blocked with the anti-FcR mAb 2.4G2, stained with the indicated
antibodies for 20 min at 4°C and then washed and resuspended
in FACS buffer for analysis. Flow cytometry was performed on
a BD FACSCalibur™. Data analysis was performed using BD
CellQuest™ Pro software. Cell-free BALF was subjected to
cytokine analysis by cytometric bead arrays (CBA) or MPO–DNA
complex analysis. The lung was snap frozen in OCT compound
and examined for in vivo NET formation.

In Vivo NET Detection

Cross sections (9 μm) of OCT-embedded frozen lung tissues
were fixed in 4% paraformaldehyde, blocked in 8% BSA in PBS
and incubated with the primary antibodies: anti-Histone H2B
(1:100 dilution; Cat # SC-8651; Santa Cruz Biotechnology), antimouse MPO (1:100 dilution; Cat # HM1051BT; Hycult Biotech)
followed by the appropriate rhodamine red- or FITC-conjugated
secondary antibody (1:100–1:200; Jackson ImmunoResearch
Laboratories). DNA was stained with DAPI. All images were
acquired with QCapture software on a Nikon Eclipse microscope.

MATERIALS AND METHODS

In Vitro NET Induction

Animals

Neutrophils were isolated from bone marrow as previously
described (9). Isolated neutrophils were seeded on Thermanox
plastic coverslips (Cat # 174950, Thermo Fisher Scientific Inc.) or
5-mm round glass coverslips (Cat # 101413-528, VWR), placed
in 24-well plates (75,000 cells/well) and incubated for 1 h at
37°C to allow adherence to coverslips. The following activating
agents were used: LPS (10 μg/ml, Cat # L2762, Sigma-Aldrich),
PMA (10 nM, cat# P8137, Sigma-Aldrich) or Sev (5,000), and
rmTNF-α (10 μg/ml, cat# 410-MT, R&D Systems). After 30 min
of stimulation, cells were fixed with 4% paraformaldehyde in
PBS overnight and the DNA was stained with Sytox green (Cat #
S7020, Invitrogen). NETs were visualized on a Nikon Eclipse
fluorescence microscope and low magnification images (40×)
were acquired with QCapture software on non-overlapping
random images (7–11 separate fields/coverslips, derived from
3 wells/condition or genotype). NETs were manually identified
on acquired images as Sytox-positive structures emanating
from neutrophils with an overall length at least twice as long
as the cell diameter (10) and expressed as percentage of neutrophils with released DNA. Each experiment was repeated at
least three times.

Dipeptidyl peptidase I−/− mice were generated in 129/SvJ as previously described (8) and backcrossed to C57BL/6J for >10 generations. Microsatellite genotyping showed that DPPI−/− mice were
99.2% congenic with C57BL/6J mice (The Jackson Laboratory).
WT C57BL/6J mice were obtained from The Jackson Laboratory.
WT and DPPI−/− mice were kept in pathogen-free environment
until the time of Sev infection. All animal experiments were performed in compliance with federal laws and in strict accordance
with the guidelines established by the Division of Comparative
Medicine at Washington University in St. Louis.

Viral Infection

Mice of 6–8 weeks of age were anesthetized with isoflurane and
inoculated intranasally (i.n.) with 2,500 50% egg infectious dose
of Sev (Fushimi strain) as previously described (5). Experimental
infection with Sev was performed in biohazard containment facility. Some animals received DNase 1 (0.5 mg i.n./mouse) on days
0–2. Cl-amidine, a pan-PAD inhibitor (cat#506282, Calbiochem)
was dissolved in DMSO/PBS (5% v/v) and administered i.p. at
10 mg/kg daily on days −2 and −1 prior to infection then twice a
Frontiers in Immunology | www.frontiersin.org
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MPO–DNA ELISA

and in plasma. The concentration of MPO–DNA complexes
in BALF and plasma was increased in Sev-infected WT mice
(Figures 1B,C). By contrast, we detected significantly lower levels
of MPO–DNA complexes in the lung and plasma of Sev-infected
DPPI−/− mice on days 2–4 PI (Figures 1B,C). DNase 1 treatment
also lowered the concentration of MPO–DNA complexes in
BALF and plasma, confirming that the release of these complexes
was partly NET dependent (Figure 1D).
In vitro, Sev enhanced NET release from TNF-primed, bone
marrow-derived WT neutrophils (Figure 2). TNF-primed
DPPI−/− neutrophils generated lower levels of NETs in response
to Sev (Figure 2) although the overall rate of Sev-induced NET
formation was lower compared to PMA or LPS stimulation
(Figure 2). Regardless of the stimulus, DPPI−/− neutrophils consistently generated lower level of NETs, consistent with the in vivo
results and previous studies (13, 14). Taken together these results
suggest that Sev can directly induce NETs; however, in the lung
milieu following Sev infection, several inflammatory cytokines
likely contribute to or enhance Sev-induced NET formation.

Anti-MPO antibody (5 μg/ml, cat# HM 1051BT, Hycult Biotech
Inc) was used to coat 96-well plate overnight at 4°C. After three
washes with washing buffer (PBS with 0.05% Tween 20), 20 μl
of BALF or plasma samples were added to the wells with 80-μl
incubation buffer containing a peroxidase-labeled anti-DNA
monoclonal antibody (dilution 1:25, cat# 11544675001, Cell
Death Detection ELISA, Roche). The plate was incubated for 2 h
at room temperature. After three washes, 100 μl of peroxidase
substrate (cat# DY999, R&D Systems) was added. The reaction
was stopped with 1M H2SO4 and OD of samples measured at
450 nm (Molecular Devices SpectraMax Plus 384). Specific OD
was obtained by subtracting total OD from background OD
generated without the addition of peroxidase-labeled anti-DNA
antibody (less than 10%).

Cytokine Analysis

Cytokine concentrations in BALF samples and co-cultures
were measured using the CBA for Mouse Inflammation Kit
(cat# 552364, BD Biosciences), according to the manufacturer’s
protocols.

DNase 1 Attenuates the Early
Sev-Induced Alveolar Inflammation

In Vitro Co-cultures

We have previously shown that Sev infection induced the expression of several cytokines/chemokines and absence of DPPI
dampened this acute inflammatory response (5). To determine
whether NETs modulated the acute response following Sev infection, we examined alveolar leukocyte accumulation and cytokine
expression in WT mice treated with DNase 1. Administration of
DNase 1 (i.n.) significantly reduced the total number of leukocytes recruited to the alveolar space (Figure 3). In addition, the
levels of several BALF inflammatory cytokines, including TNF-α
and IL-6 were suppressed with DNase 1 treatment (Figure 3). The
extent of suppression with DNase1 treatment was equivalent to
that observed with DPPI−/− mice (Figure 3). DNase 1 treatment
not only suppressed the acute cytokine response but also dampened the recruitment and activation of CD4+ and CD8+ T cells, as
well as plasmacytoid DCs (CD317+ CD11c+ CD11b− Siglec-H+)
(Figure 4).
To further confirm that NET plays a role in the early inflammatory responses to Sev infection, we administered Cl-amidine,
a pan PAD inhibitor with preferential irreversible inactivation of
the calcium bound form of PAD4 (15, 16) to Sev-infected mice.
PAD4 catalyzes the conversion of specific arginine residues to citrulline (17) and is essential for the formation of NETs via PAD4mediated citrullination of histones (18). Cl-amidine suppressed
neutrophil accumulation and inflammatory cytokine release in
the alveolar space (Figure 5). Combined with the DNase 1 treatment results, these findings further confirmed the involvement of
NETs in early host responses to Sev.

Murine bone marrow cells were cultured in vitro with GM-CSF
(10 μg/ml, cat# PMC2015, Thermo Fisher Scientific) and Il-4
(5 μg/ml, cat# 404-ML/CF, R&D Systems) for 7 days. Cultured
cells were plated in 24-well plates at 0.5 × 106 cells/well. BALF collected on day 3 from Sev-infected mice were added at a final dilution of 44%. Supernatants were collected 2 days later and cytokine
concentrations were analyzed by CBA. Baseline cytokine levels
from BMDCs alone are subtracted from co-culture cytokine
levels and values are presented as% of mean WT level, which is
set at 100%.

Statistical Analysis

Comparisons between two groups were performed by student’s
t-test and comparisons between multiple groups (≥3) were performed by one-way ANOVA and Bonferroni’s correction for multiple comparisons was performed. Numerical data were expressed
as mean ± SEM. P values <0.05 were considered significant.

RESULTS
Sev Infection Induces NET Formation
In Vivo and In Vitro

WT C57BL/6J and DPPI-deficient (DPPI−/−) mice were infected
i.n. with 2,500 50% egg infectious dose of Sev as previously
described (5). On day 3 PI, mice were sacrificed and their lung
examined for NET formation by immunostaining with anti-
histone and anti-MPO antibodies; DAPI stained DNA. NETs were
easily detected in WT lung but greatly decreased in DPPI−/− mice
(Figure 1A). Concomitant administration of DNase 1, which
dismantled NETs (11, 12), also suppressed Sev-induced NET
formation in Sev-infected WT mice (Figure 1A).
To further quantify the NET content in Sev-infected mice we
measured concentration of MPO–DNA complexes in the BALF
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Dendritic Cells/Macrophages to
Release Inflammatory Cytokines

Previous studies suggest that the early phase antiviral cytokine
response correlates with chronic lung immunopathology, including the airway remodeling and AHR that accompany the asthma
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FIGURE 1 | Sev infection induces pulmonary NETs. WT and DPPI−/− mice were infected with Sev and their blood, lung, and BALF harvested on the indicated
day PI. (A) Frozen lung sections from day 3 PI were stained for histone (green) and MPO (red). DAPI stained nuclei blue. The absence of DPPI and DNase 1
treatment suppressed NET formation. (B–D) BALF fluid and plasma from Sev-infected animals were collected on the indicated days and assayed for levels of
MPO–DNA complexes. Values represent increase over baseline (obtained from uninfected mice) and expressed as mean ± SEM, n = at least five mice per
genotype/treatment group. Scale bars = 100 μm. *P < 0.05, ***P < 0.001.

phenotype (19). In addition to Th2-types cytokines, Th1 cytokines,
such as TNF-α, have also been shown to play an important role
in the pathogenesis of asthma. TNF-α is increased in the sputum
of patients with asthma (20, 21), aggrevates AHR (22) as well as
recruit inflammatory cells in animals (23). Blockade of TNF-α
significantly inhibits AHR and reduces airway inflammation (24).
To this end, we examined whether BALF-derived NETs from

Frontiers in Immunology | www.frontiersin.org

Sev-infected mice modulated TNF-α (and other inflammatory
cytokine) release from in vitro GM-CSF-induced BMDCs that
comprise conventional DCs and macrophages (25). We observed
that NET-containing BALF from WT Sev-infected mice directly
stimulated BMDCs to release substantial amount of TNF-α (as well
as IL-6 and MCP-1) while BALF from DPPI−/− mice and animals
treated with DNase 1 was less efficient (Figure 6A). Cl-amidine
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FIGURE 2 | Absence of DPPI attenuates NET formation in vitro. (A) Bone marrow-derived neutrophils from WT and DPPI−/− mice were stimulated with
TNF-α + Sev, PMA, or LPS for 30 min and stained for DNA with Sytox green. (B,C) Quantification of NETs with different stimuli (mean ± SEM derived from three
separate experiments). *P < 0.05, **P < 0.01, ***P < 0.001.

FIGURE 3 | DNase 1 treatment suppresses the acute Sev-induced inflammatory responses. WT and DPPI−/− mice were infected with Sev and their BALF
harvested on day 3 PI. Some WT mice received DNase 1 i.n. on days 0–2 PI. The cells were enumerated and cell-free BALF assayed for cytokines by CBA. Values
represent mean ± SEM, n = 4–5 mice per genotype/treatment group. *P < 0.05, **P < 0.01, ***P < 0.001, ns = not significant.
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FIGURE 4 | DNase 1 treatment suppresses immune cell recruitment and activation. WT mice were infected with Sev and treated i.n. with HBSS or DNase 1.
Cells were harvested from BAL on day 3 PI and analyzed for CD4, CD8, CD69 (activation marker), and CD317+CD11c+CD11b-SiglecH+ (plasmacytoid dendritic
cell markers) by multicolor FACS analysis. Values represent mean ± SEM, n = 4–5 mice/treatment group. *P < 0.05, **P < 0.01.

FIGURE 5 | Cl-amidine administration attenuates acute Sev-induced inflammatory responses. WT mice were administered Cl-amidine i.p. daily 2 days
prior to infection and treatment was continued (twice a day) until sacrifice as detailed in Section “Materials and Methods.” Controls received the same i.p. regimen of
DMSO/PBS (5% v/v). On day 3 BALF was collected; cells were enumerated and cell-free BALF assayed for cytokines by CBA. Values represent mean ± SEM, n = 5
mice/treatment group. **P < 0.01; ***P = 0.001; note that IL-6 level in Cl-amidine treatment group approached statistical significance (P = 0.06).

treatment also significantly attenuated the release of inflammatory cytokines by BALF-stimulated BMDCs (Figure 6B). Taken
together, these above findings suggest that NETs released by
recruited neutrophils play an important role in shaping the early
immune response that likely impacts the Sev-induced chronic
lung immunopathology.

asthma, however, comprises 50% of asthma and is often associated with accumulation of neutrophils in the airways, possibly
due to bacterial endotoxin exposure as well as viral infections
(32). Neutrophils are often present in acute asthma exacerbations
(33) and noted in specific circumstances, such as status asthmaticus (34) but their role in asthma pathogenesis has not been
extensively explored. A more recent study suggests that NETs are
generated in human atopic asthmatic airways (35); however, their
pathophysiologic role in allergic asthma also remains undefined.
Using a physiologic murine model of Sev-induced asthma phenotype, we previously established a critical role for neutrophils
and neutrophil-associated DPPI in the disease pathogenesis (5).
In the studies herein, we further extend the investigation to show
that neutrophil-derived DPPI is an important mediator of NET
formation and NETs mediate the early inflammatory responses
in Sev infection.
In addition to Sev-induced asthma phenotype, the absence
of DPPI protects against various inflammatory conditions,

DISCUSSION
Neutrophil extracellular traps can have anti- and pro-inflammatory
effects on disease pathogenesis. On the one hand, NETs have been
shown to promote the resolution of neutrophilic inflammation
in monosodium urate crystal-induced arthritis (gout) (26). On
the other hand, NETs are increasingly implicated in driving the
pathogenesis of various diseases (11, 27–31). Their role in asthma
development, however, remains largely unknown. Asthma is considered an inflammatory disease involving different mediators
and cell types, with eosinophil predominance. Non-eosinophilic
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FIGURE 6 | BALF from Sev-infected mice stimulates cytokine release from BMDCs. WT and DPPI−/− mice were infected with Sev on day 0. Some WT mice
were treated i.n. with DNase 1 or Cl-amidine as detailed in Section “Materials and Methods.” BALF was harvested on day 3 PI and cells were pelleted. The cell-free
BALF from each genotype/treatment was added to BMDCs at a final dilution of 44%. The supernatant was collected after 48 h and assayed for cytokine levels with
CBA. (A) Cytokine levels from co-cultures of BMDCs with BALF from WT, DPPI−/−, or DNase 1-treated (Tx) mice. (B) Cytokine levels from co-cultures of BMDCs with
BALF from Cl-amidine-treated mice. Values represent mean ± SEM, n = 4–6 mice/treatment group. The mean of WT cytokine levels for each experimental condition
was set at 100%; values are expressed as% of mean WT level. *P < 0.05, **P < 0.01, ***P < 0.001, ns = not significant.

including preclinical models of rheumatoid arthritis (36), sepsis
(37), abdominal aortic aneurysm (38), and ANCA-associated
glomerulonephritis (39). DPPI deficiency also attenuates early
atherosclerotic lesion in LDL-receptor-deficient mice (40).
A recent report established that the absence of DPPI abrogates
in vitro NET formation (13). DPPI is a ubiquitously expressed
cysteine protease that is required for the expression of neutrophil
serine proteases (NSPs), neutrophil elastase (NE), cathepsin G
(CG) and proteinase 3 (PR3) in mature neutrophils (13, 36, 41).
The role of NSPs in NET formation is well accepted (42). It is
suggested that NE, but not CG or PR3, translocates to the nucleus
where it contributes to chromatin decondensation by cleaving
histones, an essential step in NET formation (43, 44). However,
Martinod et al. recently showed that NE is dispensable for in vitro
and in vivo NETs (45). Consistent with these results, we found
that murine NE-deficient neutrophils release normal levels of
NETs in vitro in response to various stimuli while the absence of
NE and PR3 results in a NET defect similar to that observed with
DPPI-deficient neutrophils (14). These discrepancies may reflect
species-dependent requirements for NET formation, as previous
studies used human neutrophils and NSP inhibitors.
Airway remodeling is an important histologic and structural change seen in asthma. It is a complex and incompletely
understood process, involving several cell types and mediators.
Neutrophils have been linked to airway remodeling presumably
through their ability to release proteases, including metalloproteases and NE that induce degradation of extracellular matrix and
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modulate inflammatory cell trafficking (46–48). Herein, we show
that DNase 1 treatment significantly reduced the recruitment and
activation of leukocytes, including CD4+ and CD8+ T cells, in
the acute phase PI and suppressed inflammatory cytokine release.
BALF from DNase 1- and Cl-amidine-treated animals was also
less efficient at stimulating bone marrow-derived macrophages
and DCs from releasing inflammatory cytokines. Taken together
these results suggest that NETs released during the acute phase
of Sev infection induce airway inflammation, leading to the
elaboration of inflammatory cytokines that further recruit and
activate immune cells, thus promoting the eventual chronic
asthma phenotype.
In summary, these findings suggest that controlling neutrophil
activation and NET formation in non-eosinophilic asthma may
attenuate acute exacerbations and potentially prevent further
airway remodeling.
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